Toward identifying a cellular determinant of telomerase repression.
暂无分享,去创建一个
[1] C. Cooper,et al. Telomerase repressor sequences on chromosome 3 and induction of permanent growth arrest in human breast cancer cells. , 1999, Journal of the National Cancer Institute.
[2] J. Sedivy. Can ends justify the means?: telomeres and the mechanisms of replicative senescence and immortalization in mammalian cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[3] A. Lindblom,et al. Loss of heterozygosity at chromosome 3p correlates with telomerase activity in renal cell carcinoma. , 1998, International journal of oncology.
[4] M. Oshimura,et al. Repression of the telomerase catalytic subunit by a gene on human chromosome 3 that induces cellular senescence , 1998, Molecular carcinogenesis.
[5] J. Shay,et al. Telomerase in cancer: diagnostic, prognostic, and therapeutic implications. , 1998, The cancer journal from Scientific American.
[6] S. Benchimol,et al. Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span , 1998, Current Biology.
[7] C. Harley,et al. Extension of life-span by introduction of telomerase into normal human cells. , 1998, Science.
[8] C. Reznikoff,et al. Minimal deletion of 3p13→14.2 associated with immortalization of human uroepithelial cells , 1998, Genes, chromosomes & cancer.
[9] R. Weinberg,et al. hEST2, the Putative Human Telomerase Catalytic Subunit Gene, Is Up-Regulated in Tumor Cells and during Immortalization , 1997, Cell.
[10] I. Wistuba,et al. Telomerase expression in respiratory epithelium during the multistage pathogenesis of lung carcinomas. , 1997, Cancer research.
[11] T R Hughes,et al. Reverse transcriptase motifs in the catalytic subunit of telomerase. , 1997, Science.
[12] J. Shay,et al. A survey of telomerase activity in human cancer. , 1997, European journal of cancer.
[13] J. Campisi. The biology of replicative senescence. , 1997, European journal of cancer.
[14] M. Oshimura,et al. Multiple pathways to cellular senescence: role of telomerase repressors. , 1997, European journal of cancer.
[15] J. Sedat,et al. Block in Anaphase Chromosome Separation Caused by a Telomerase Template Mutation , 1997, Science.
[16] A. Gazdar,et al. Telomerase in the early detection of cancer. , 1997, Journal of clinical pathology.
[17] June Corwin,et al. Telomerase Catalytic Subunit Homologs from Fission Yeast and Human , 1997 .
[18] C. Meijer,et al. Transition of human papillomavirus type 16 and 18 transfected human foreskin keratinocytes towards immortality: activation of telomerase and allele losses at 3p, 10p, 11q and/or 18q. , 1996, Oncogene.
[19] J. Shay,et al. Telomerase activity in human cancer. , 1996, Current opinion in oncology.
[20] J. Shay,et al. Telomerase activity in human germline and embryonic tissues and cells. , 1996, Developmental genetics.
[21] H. Erdjument-Bromage,et al. A Human Telomeric Protein , 1995, Science.
[22] M. Oshimura,et al. Restoration of the Cellular Senescence Program and Repression of Telomerase by Human Chromosome 3 , 1995, Japanese journal of cancer research : Gann.
[23] et al.,et al. The RNA component of human telomerase , 1995, Science.
[24] M. S. Rhyu. Telomeres, telomerase, and immortality. , 1995, Journal of the National Cancer Institute.
[25] G. Morin. Is telomerase a universal cancer target? , 1995, Journal of the National Cancer Institute.
[26] Keiko Hiyama,et al. Correlating telomerase activity levels with human neuroblastoma outcomes , 1995, Nature Medicine.
[27] J. Shay,et al. Forward: Aging and cancer: Are telomeres and telomerase the connection? , 2001 .
[28] C B Harley,et al. Specific association of human telomerase activity with immortal cells and cancer. , 1994, Science.
[29] C B Harley,et al. Telomere length predicts replicative capacity of human fibroblasts. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[30] R. Sager. Senescence as a mode of tumor suppression. , 1991, Environmental health perspectives.
[31] J. Shay,et al. Defining the molecular mechanisms of human cell immortalization. , 1991, Biochimica et biophysica acta.
[32] C B Harley,et al. Telomere loss: mitotic clock or genetic time bomb? , 1991, Mutation research.
[33] H. Cooke,et al. In vivo loss of telomeric repeats with age in humans. , 1991, Mutation research.
[34] Robin C. Allshire,et al. Telomere reduction in human colorectal carcinoma and with ageing , 1990, Nature.
[35] C. Harley,et al. Telomeres shorten during ageing of human fibroblasts , 1990, Nature.
[36] R. Myers,et al. Structure and variability of human chromosome ends , 1990, Molecular and cellular biology.
[37] G. Morin. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats , 1989, Cell.
[38] E. Blackburn,et al. A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis , 1989, Nature.
[39] V A Zakian,et al. Structure and function of telomeres. , 1989, Annual review of genetics.
[40] L. S. Cram,et al. A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[41] Carol W. Greider,et al. Identification of a specific telomere terminal transferase activity in tetrahymena extracts , 1985, Cell.
[42] T. Norwood,et al. Dominance of the senescent phenotype in heterokaryons between replicative and post-replicative human fibroblast-like cells. , 1974, Proceedings of the National Academy of Sciences of the United States of America.
[43] J. Watson. Origin of concatemeric T7 DNA. , 1972, Nature: New biology.
[44] A. Olovnikov. [Principle of marginotomy in template synthesis of polynucleotides]. , 1971, Doklady Akademii nauk SSSR.
[45] L. Hayflick. THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS. , 1965, Experimental cell research.